Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

被引：0
|
作者：
Alice Mariottini
Anna Maria Repice
Alessandro Barilaro
Luca Massacesi
机构：
[1] University of Florence,Department of Neurosciences, Drug and Child Health
[2] Tuscany Region Multiple Sclerosis Referral Centre,undefined
[3] Neurology 2,undefined
[4] University Hospital of Careggi,undefined
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4095 / 4097
页数：2
相关论文
共 50 条
  • [31] Anti-SARS-CoV-2 (COVID-19) vaccination efficacy in patients with severe neuromuscular diseases
    Damour, A.
    Delalande, P.
    Cordelieres, F.
    Lafon, M. E.
    Faure, M.
    Segovia-Kueny, S.
    Stalens, C.
    Mathis, S.
    Spinazzi, M.
    Violleau, M. H.
    Wodrich, H.
    Sole, G.
    REVUE NEUROLOGIQUE, 2023, 179 (09) : 983 - 992
  • [32] SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination
    Wagenhaeuser, Isabell
    Knies, Kerstin
    Pscheidl, Tamara
    Eisenmann, Michael
    Flemming, Sven
    Petri, Nils
    Mcdonogh, Miriam
    Scherzad, Agmal
    Zeller, Daniel
    Gesierich, Anja
    Seitz, Anna Katharina
    Taurines, Regina
    Ernestus, Ralf-Ingo
    Forster, Johannes
    Weismann, Dirk
    Weissbrich, Benedikt
    Liese, Johannes
    Hartel, Christoph
    Kurzai, Oliver
    Doelken, Lars
    Gabel, Alexander
    Krone, Manuel
    EBIOMEDICINE, 2024, 109
  • [33] Reconstruction of incidence reporting rate for SARS-CoV-2 Delta variant of COVID-19 pandemic in the US
    Smirnova, Alexandra
    Baroonian, Mona
    INFECTIOUS DISEASE MODELLING, 2024, 9 (01) : 70 - 83
  • [34] Anti-S2 Protection in COVID-19 Infection and SARS-CoV-2 Spike Vaccination
    Canziani, Gabriela A.
    Tang, Jackie
    Nangarlia, Aakansha
    Zhang, Shiyu
    Fazloon-Hassen, Farah
    Taludker, Choya
    Connors, Jennifer
    Cusimano, Gina
    Bernui, Mariana
    Bell, Matt
    FASEB JOURNAL, 2022, 36
  • [35] Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts
    Dryden-Peterson, Scott
    Velasquez, Gustavo E.
    Stopka, Thomas J.
    Davey, Sonya
    Gandhi, Rajesh T.
    Lockman, Shahin
    Ojikutu, Bisola O.
    JAMA HEALTH FORUM, 2021, 2 (09): : E212666
  • [36] Wastewater surveillance of SARS-CoV-2 and chemical markers in campus dormitories in an evolving COVID-19 pandemic
    Mohapatra, Sanjeeb
    Bhatia, Sumedha
    Senaratna, Kavindra Yohan Kuhatheva
    Jong, Mui-Choo
    Lim, Chun Min Benjamin
    Gangesh, G. Reuben
    Lee, Jia Xiong
    Giek, Goh Shin
    Cheung, Callie
    Lin, Yutao
    You, Luhua
    Yong, Ng How
    Peng, Lim Cheh
    Wong, Judith Chui Ching
    Ching, Ng Lee
    Gin, Karina Yew-Hoong
    JOURNAL OF HAZARDOUS MATERIALS, 2023, 446
  • [37] Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic
    Mahallawi, Waleed
    Ibrahim, Nadir
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] SARS-CoV-2 laboratory surveillance during the first year of the COVID-19 pandemic in southern Brazil
    Baethgen, Ludmila Fiorenzano
    da Veiga, Ana Beatriz Gorini
    Salvato, Richard Steiner
    de Carvalho, Talita Giacomet
    Rispoli, Thaiane
    Schiefelbein, Sun Hee
    Martins, Leticia Garay
    Nunes, Zenaida Marion Alves
    Schaurich, Anelise Praetzel
    Timm, Loeci Natalina
    Ramos, Rosane Campanher
    Bastos, Cynthia Goulart Molina
    Gregianini, Tatiana Schaffer
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2023, 56
  • [39] Adverse events following immunization against SARS-CoV-2 (covid-19) in the state of Minas Gerais
    da Silva, Roberta Barros
    Rodrigues da Silva, Thales Philipe
    Sayuri Sato, Ana Paula
    Felix Lana, Francisco Carlos
    Gusmao, Josianne Dias
    Almeida Souza, Janaina Fonseca
    Matozinhos, Fernanda Penido
    REVISTA DE SAUDE PUBLICA, 2021, 55 : 01 - 10
  • [40] A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan
    Takeuchi, Yoshinori
    Iwagami, Masao
    Ono, Sachiko
    Michihata, Nobuaki
    Uemura, Kohei
    Yasunaga, Hideo
    VACCINE, 2022, 40 (52) : 7622 - 7630
12345